U.S. flag

An official website of the United States government

NM_000492.3(CFTR):c.1521_1523del (p.Phe508del) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 1, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002243627.9

Allele description [Variation Report for NM_000492.3(CFTR):c.1521_1523del (p.Phe508del)]

NM_000492.3(CFTR):c.1521_1523del (p.Phe508del)

Genes:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
CFTR-AS1:CFTR antisense RNA 1 [Gene - HGNC]
Variant type:
Deletion
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.3(CFTR):c.1521_1523del (p.Phe508del)
Other names:
F508del; deltaF508; F508delF; DF508; Phe508del; DeltaF508; [delta]F508
HGVS:
  • NC_000007.13:g.117199645_117199647del
  • NC_000007.14:g.117559592_117559594del
  • NG_016465.4:g.98809_98811del
  • NM_000492.4:c.1521_1523delMANE SELECT
  • NP_000483.3:p.Phe508del
  • NP_000483.3:p.Phe508del
  • LRG_663t1:c.1521_1523del
  • LRG_663:g.98809_98811del
  • LRG_663p1:p.Phe508del
  • NC_000007.13:g.117199645_117199647del
  • NC_000007.13:g.117199646_117199648del
  • NC_000007.13:g.117199646_117199648del
  • NC_000007.13:g.117199646_117199648delCTT
  • NC_000007.14:g.117559592_117559594del
  • NC_000007.14:g.117559592_117559594delCTT
  • NG_016465.1:g.84630_84632delCTT
  • NM_000492.3:c.1520_1522del
  • NM_000492.3:c.1520_1522delTCT
  • NM_000492.3:c.1521_1523del
  • NM_000492.3:c.1521_1523delCTT
  • NM_000492.4:c.1520_1522delMANE SELECT
  • NM_000492.4:c.1520_1522delTCTMANE SELECT
  • NM_000492.4:c.1521_1523delCTTMANE SELECT
Protein change:
PHE508DEL
Links:
PharmGKB Clinical Annotation: 981755820; OMIM: 602421.0001; dbSNP: rs113993960
NCBI 1000 Genomes Browser:
rs113993960
Molecular consequence:
  • NM_000492.4:c.1521_1523del - inframe_deletion - [Sequence Ontology: SO:0001822]
Functional consequence:
loss_of_function_variant [Sequence Ontology: SO:0002054]

Condition(s)

Name:
Cystic fibrosis (CF)
Synonyms:
Mucoviscidosis
Identifiers:
MONDO: MONDO:0009061; MedGen: C0010674; Orphanet: 586; OMIM: 219700
Name:
Hereditary pancreatitis (PCTT)
Synonyms:
Hereditary chronic pancreatitis
Identifiers:
MONDO: MONDO:0008185; MedGen: C0238339; Orphanet: 676; OMIM: 167800

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002512246Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 1, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein, SCV002512246.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

ACMG classification criteria: PS3 supporting, PS4 strong, PM3 very strong, PM3 strong, PM4 moderate, PP3 supporting

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 7, 2024